Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-26-012963·Bluejay Diagnostics, Inc.
Schedule 13G ownership disclosure
BLUEJAY DIAGNOSTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 095633608
Event date: 2026-02-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Northstrive Fund II LP
Shares: 11,000.00 · Class: 1.55%
- Braeden Lichti
Shares: 35,500.00 · Class: 5.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-012963
- Form type
- SCHEDULE 13G
- Filer
- Bluejay Diagnostics, Inc.
- CIK
- CIK 1704287
- Filed
- Feb 05, 2026
- Reporting period
- Feb 05, 2026
- Description
- Schedule 13G beneficial ownership